Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast.

This publication has 22 references indexed in Scilit:

• Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.
  Thorax, 1991
• Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes
  Trends in Pharmacological Sciences, 1991
• Calcium-independent phosphodiesterase inhibitors as putative antidepressants: [3-(bicycloalkyloxy)-4-methoxyphenyl-2-imidazolidinones
  Journal of Medicinal Chemistry, 1991
• Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors
  Trends in Pharmacological Sciences, 1990
• Effects of novel catechol ether imidazolidinones on calcium‐independent phosphodiesterase activity, [³H]rolipram binding, and reserpine‐induced hypothermia in mice
  Drug Development Research, 1990
• Isolation of similar rolipram‐inhibitable cyclic‐AMP‐specific phosphodiesterases from rat brain and heart
  European Journal of Biochemistry, 1989
• A New Generation of Phosphodiesterase Inhibitors: Multiple Molecular Forms of Phosphodiesterase and the Potential for Drug Selectivity
  Journal of Medicinal Chemistry, 1985
• Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors
  Neuropharmacology, 1983
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973